LIGACHEM Trademark

Trademark Overview


On Friday, September 6, 2024, a trademark application was filed for LIGACHEM with the United States Patent and Trademark Office. The USPTO has given the LIGACHEM trademark a serial number of 79410373. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 21, 2024. This trademark is owned by LigaChem Biosciences Inc.. The LIGACHEM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; biomedical research services; biological research and analysis; medical research in the field of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; research and development of medicines; biotechnology research; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; research in the field of pharmaceuticals; scientific research for medical purposes in the field of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical research services; medical research laboratory services; research of...

General Information


Serial Number79410373
Word MarkLIGACHEM
Filing DateFriday, September 6, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development of vaccines and medicines; biomedical research services; biological research and analysis; medical research in the field of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; research and development of medicines; biotechnology research; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; research in the field of pharmaceuticals; scientific research for medical purposes in the field of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical research services; medical research laboratory services; research of medicines; platform as a service (PAAS) featuring computer software platforms for research and development in the field of pharmaceuticals, biotechnology and medicine; laboratory research services relating to pharmaceuticals; research services in the field of pharmaceutical preparations; testing of pharmaceuticals; clinical research in the field of medicine; chemical research and analysis.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLigaChem Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, November 21, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 2, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 5, 2024APPLICATION FILING RECEIPT MAILED